Share on :

Asset Summary

Weekly Performance Report for GILD ETF: Week 51, 2024

Summary: The Weekly started with GILD ETF opening at $91.96 and closing at $92.57. The ETF showed resilience throughout the Weekly, with the highest price observed at $93.59 and the lowest at $90.27. The underlying asset had a trading range of $3.32 Overall, it was a positive trading Weekly for GILD ETF, reflecting investor optimism and market activity.

Change in Closing Price: There was a net increase of $0.61 or 0.66% in the closing price from the opening to the closing price over the Weekly.

Volume Analysis: Trading volume for GILD ETF was 51,216,328 units during Week 51, indicating active market participation and investor interest.

Opening Price: The Weekly started at $91.96.

Highest Price: The highest price observed during the Weekly was $93.59.

Lowest Price: The lowest price observed during the Weekly was $90.27.

Closing Price: The Weekly ended at $92.57.

Asset Performance Metrics and Risk Characteristics:

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. By using various technical indicators and chart patterns, investors can gain insights into market trends, price momentum, and potential turning points. This section delves into essential technical metrics, including moving averages, pivot points, and other indicators that provide a snapshot of an asset's current technical stance. Analyzing these indicators helps investors identify entry and exit points, assess market sentiment, and refine their trading strategies. Explore the following technical analysis data to understand the asset's performance dynamics and make better-informed decisions.

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Transform Your GILD Trading Now

Discover unparalleled trading insights with Rankmytrade. Our automated system offers advanced analysis and technical indicators for GILD, aimed at optimizing your trading decisions. Transform your trading strategy now and get ahead in the market now!

Maximize Results Now

Frequently Asked Questions

Yes, Gilead Sciences is publicly traded on the NASDAQ under the ticker symbol GILD.

Yes, Gilead Sciences pays dividends. Check their investor relations page for the latest information on dividend amounts.

Gilead has a robust pipeline of investigational therapies targeting various diseases, including multiple candidates in late-stage clinical trials.

You can buy GILD stock through a brokerage account or consult a financial advisor.

Gilead Sciences is headquartered in Foster City, California, USA.

Gilead has made several strategic acquisitions to enhance its research capabilities and expand its product portfolio; check their investor reports for specifics.

Gilead fosters a culture of collaboration, innovation, and integrity, encouraging employees to contribute to meaningful work.

News about Gilead can be found on their official website, through financial news outlets, and via press releases.

Gilead focuses on developing therapies for HIV, liver diseases, cancer, inflammatory diseases, and other serious conditions.

Gilead’s research and products have significantly impacted global health, particularly in treating infectious diseases like HIV and hepatitis.

Improve Your GILD Trading Now

Experience the future of trading with Rank My Trade. Our advanced system delivers in-depth analysis and insights for GILD, utilizing state-of-the-art technical tools and strategies. Boost your investment success with us and see how we can elevate your trading results!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. RankMyTrade (RMT) has not independently verified this data and does not guarantee its accuracy. The information and calculations provided by RankMyTrade are for educational and informational purposes only and should not be construed as financial or investment advice.

With any investment, your capital is at risk. The value of your portfolio go down as well as up. Past performance is no guarantee of future results. By using this website, you accept our Terms of Service, Privacy Policy, and Payment Agreement.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind. Unless otherwise noted, RankMyTrade and its affiliates are not partners, affiliates, or licensees of these companies.

Supported Assets & ETFs